We believe companies should serve humanity and service to our fellow man is at the core of our being. We contribute by research as well as other avenues of charity.
We are looking for Behavioral Health organizations and practices to participate in a SymptomTrack Beta Test. We will be working one on one with successful test applicants to help integrate a premier Evidence Based Medicine service offering. To apply for the Beta Test please contact us at the link below.
American Psychotherapy Association members qualify for a discount when purchasing through their Association member portal. Not a member yet?
Did you know that on October 7, 2003, the US government obtained US Patent 6630507 titled “Cannabinoids as antioxidants and neuroprotectants”? Or, that the AMA has declared medical cannabis a medicine? Or, astoundingly that Cannabinoids have been found to reduce tumors in a study by Dr. Wai Liu, an oncologist at St. George’s University of London?
Enigami offers a commercial product to help patients understand the relationship between their medications (including medical cannabis) and their medical conditions. This knowledge is currently unavailable though in the future, our research, will aggregate data to explain these complex relationships. This personal health record, called TreatmentGuide sm, will help patients learn which medication regimens are appropriate for their treatment.
The Veterans Health Administration (VHA) is overwhelmed and the established treatments for Post-Traumatic Stress related disorders (PTSD) are not sufficiently effective. To address this problem, Enigami Medical Cannabis, LLC is working with Patients Out of Time and other Supporters to conduct a national study, “Veterans, Post-Traumatic Stress, and Medical Cannabis”. To learn more click here.
Health Information Technology (HIT) is about the power of Evidence Based Treatment and helps your facility improve patient engagement, stay competitive and stay in the game.